{"title":"Artificial intelligence algorithm optimization and application in patient-based real-time quality control (PBRTQC)","authors":"Bowen Su , Yanpeng Zhang , Xiaomin Shi","doi":"10.1016/j.cca.2026.120946","DOIUrl":null,"url":null,"abstract":"<div><div>Patient-based real-time quality control (PBRTQC) serves as a vital supplement to quality management in clinical laboratories. Its core principle is to monitor the testing process in real time and continuously through patient test data. As artificial intelligence (AI) technology develops rapidly, AI has provided novel pathways for the innovation of PBRTQC algorithms and drives its transition from a traditional statistics-driven model to intelligent monitoring. This review systematically summarizes the progress of AI-driven PBRTQC algorithm optimization. Meanwhile, it provides a detailed account of the clinical applications of the AI-PBRTQC monitoring platform. These applications encompass timely quality control early warning, homogeneous monitoring across multiple settings, precise quality control in complex clinical settings, anomaly traceability and subsequent correction. In addition, this review offers an in-depth analysis of the challenges that arise during the practical implementation of AI-PBRTQC. These include technical limitations, shortage of professional talents, system compatibility barriers, and lagging standardization and regulation. It also explores future development trends and provides valuable references for the intelligent upgrade of PBRTQC.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"587 ","pages":"Article 120946"},"PeriodicalIF":2.9000,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898126001282","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Patient-based real-time quality control (PBRTQC) serves as a vital supplement to quality management in clinical laboratories. Its core principle is to monitor the testing process in real time and continuously through patient test data. As artificial intelligence (AI) technology develops rapidly, AI has provided novel pathways for the innovation of PBRTQC algorithms and drives its transition from a traditional statistics-driven model to intelligent monitoring. This review systematically summarizes the progress of AI-driven PBRTQC algorithm optimization. Meanwhile, it provides a detailed account of the clinical applications of the AI-PBRTQC monitoring platform. These applications encompass timely quality control early warning, homogeneous monitoring across multiple settings, precise quality control in complex clinical settings, anomaly traceability and subsequent correction. In addition, this review offers an in-depth analysis of the challenges that arise during the practical implementation of AI-PBRTQC. These include technical limitations, shortage of professional talents, system compatibility barriers, and lagging standardization and regulation. It also explores future development trends and provides valuable references for the intelligent upgrade of PBRTQC.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.